May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy

Filings synced 13:22 · Prices: prior close 30 Oct

LLY

Eli Lilly and Co.

NYSE · Pharmaceutical preparations (SIC 2834) · FY ends 31 Dec

Peers

NVOMRKPFEABBV5 of 12 companies

Columns

Market cap †Revenue (TTM)Revenue growthGross marginOperating marginP/S †P/E †7 of 8


LLYEli Lilly and Co.(opens in a new tab)	$1.27T	$86.46B	+45.5%	83.6%	—	14.64×	46.0×
NVONovo Nordisk A S(opens in a new tab)	—	$46.82B	+11.1%	81.0%	41.3%	—	—
MRKMerck & Co., Inc.(opens in a new tab)	$369.36B	$66.57B	+4.6%	73.0%	—	5.55×	118.7×
PFEPfizer Inc.(opens in a new tab)	$173.82B	$63.70B	−0.2%	73.2%	—	2.73×	40.1×
ABBVAbbVie Inc.(opens in a new tab)	$522.12B	$64.39B	+10.4%	71.5%	26.2%	8.11×	83.3×
Medianpeers, excl. LLY	$369.36B	$64.04B	+7.5%	73.1%	33.8%	5.55×	83.3×

Fundamentals: company filings, trailing twelve months as of each latest report. † Price-based columns: last sale on IEX, prior session 30 Oct, ÷ TTM as filed; “—” when a price is more than a week old or a figure isn’t meaningful. Click any column header to sort; click again to reverse. Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.vpside.com